AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30283911 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid and/or vitamin B12 (in meta-analysis)
Number of subjects: 1021
Study 30283911 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo in meta-analysis)
Number of subjects: 1021
Study 27523051 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg)
Number of subjects: 85
Study 27523051 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron (4 mg)
Number of subjects: 85
Study 24721352 — intervention group
Group type: EXPERIMENTAL
Intervention: Penehyclidine inhalation
Number of subjects: 90
Study 24721352 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide inhalation
Number of subjects: 90
Study 24721352 — intervention group
Group type: COMPARATOR
Intervention: Normal saline inhalation
Number of subjects: 90
Study 24573620 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% povidone-iodine
Number of subjects: 205
Study 24573620 — intervention group
Group type: COMPARATOR
Intervention: 0.5% chlorhexidine-alcohol
Number of subjects: 205
Study 19836144 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion SR (300 mg/day for 6 weeks)
Number of subjects: 24
Study 19836144 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 19836144 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study 19046091 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete supine PCNL
Number of subjects: 80
Study 19046091 — intervention group
Group type: COMPARATOR
Intervention: Prone PCNL
Number of subjects: 80
Study 16604131 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (30 microg intranasal administration) under no hydration (NH-Des)
Number of subjects: 6
Study 16604131 — intervention group
Group type: COMPARATOR
Intervention: False hydration (FH-Des)
Number of subjects: 6
Study 16604131 — intervention group
Group type: COMPARATOR
Intervention: No hydration (NH)
Number of subjects: 6
Study 16604131 — intervention group
Group type: COMPARATOR
Intervention: False hydration (FH)
Number of subjects: 6
Study 12702129 — intervention group
Group type: EXPERIMENTAL
Intervention: SQV/RTV 1000 mg/100 mg twice daily (BID) as hard gelatin capsule (HGC) for 10 days
Number of subjects: 24
Study 12702129 — intervention group
Group type: COMPARATOR
Intervention: SQV/RTV 1000 mg/100 mg twice daily (BID) as soft gelatin capsule (SGC) for 10 days
Number of subjects: 24
Study 10990524 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with Parkinson's disease
Number of subjects: 121
Study 10990524 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 121
Study 9424322 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) concentrations of TNF-alpha and CRP in patients with bacterial meningitis
Number of subjects: 0
Study 9424322 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) concentrations of TNF-alpha and CRP in differential diagnosis of meningitis
Number of subjects: 0
Study 1402495 — intervention group
Group type: COMPARATOR
Intervention: Skin shaving (control group)
Number of subjects: 80
Study 1402495 — intervention group
Group type: EXPERIMENTAL
Intervention: No skin shaving (experiment group)
Number of subjects: 80
Study 3907277 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine + Dixyrazine (50 mg/day)
Number of subjects: 63
Study 3907277 — intervention group
Group type: COMPARATOR
Intervention: Imipramine + Placebo
Number of subjects: 63
Study 3907277 — intervention group
Group type: COMPARATOR
Intervention: Imipramine + Diazepam (10 mg/day)
Number of subjects: 63
Study 3907277 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine + Dixyrazine
Number of subjects: 63
Study 3907277 — intervention group
Group type: COMPARATOR
Intervention: Imipramine + Diazepam
Number of subjects: 63
Study 29621908 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring (TM)
Number of subjects: 82
Study 29621908 — intervention group
Group type: COMPARATOR
Intervention: Conventional follow-up
Number of subjects: 82
Study 28762106 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (part of a multicentre randomised placebo-controlled trial)
Number of subjects: 707
Study 28762106 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 707
Study 25780258 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck and shoulder stretching exercises two times/day, five days/week for four weeks
Number of subjects: 96
Study 25780258 — intervention group
Group type: COMPARATOR
Intervention: Informative brochure on proper position and ergonomics
Number of subjects: 96
Study 25780258 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercising ≥3 times/week
Number of subjects: 96
Study 24445573 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial assessments including anxiety and depression
Number of subjects: 214
Study 24445573 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical outcomes study short-form-36 (SF-36) physical and mental composite scores
Number of subjects: 214
Study 24445573 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain burden assessment
Number of subjects: 214
Study 24445573 — intervention group
Group type: COMPARATOR
Intervention: Comparison of psychosocial parameters
Number of subjects: 214
Study 22283559 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg once daily for 12 days followed by DMQ 30 mg/30 mg twice daily for 8 days (Group 1)
Number of subjects: 27
Study 22283559 — intervention group
Group type: EXPERIMENTAL
Intervention: DMQ 30 mg/30 mg twice daily for 8 days followed by paroxetine 20 mg once daily for 12 days (Group 2)
Number of subjects: 27
Study 22283559 — intervention group
Group type: COMPARATOR
Intervention: Paroxetine monotherapy
Number of subjects: 27
Study 22283559 — intervention group
Group type: COMPARATOR
Intervention: DMQ alone
Number of subjects: 27
Study 22283559 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (DMQ + paroxetine)
Number of subjects: 27
Study 22283559 — intervention group
Group type: COMPARATOR
Intervention: Paroxetine alone
Number of subjects: 27
Study 22283559 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (paroxetine + DMQ)
Number of subjects: 27
Study 20024591 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment with hop rho iso-alpha acids (200 mg), berberine sulfate trihydrate (100 mg), vitamin D3 (500 IU), and vitamin K1 (500 mcg), twice daily
Number of subjects: 32
Study 20024591 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 20024591 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment with hop rho iso-alpha acids, berberine sulfate trihydrate, vitamin D3 and vitamin K1
Number of subjects: 32
Study 18672608 — intervention group
Group type: EXPERIMENTAL
Intervention: 25-gauge Pajunk(AE) spinal needle
Number of subjects: 91
Study 18672608 — intervention group
Group type: COMPARATOR
Intervention: 27-gauge Quincke spinal needle
Number of subjects: 91
Study 18672608 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Pajunk(AE) and Quincke)
Number of subjects: 91
Study 16448251 — intervention group
Group type: EXPERIMENTAL
Intervention: Teeth washed and immersed in iodine solution (experimental group)
Number of subjects: 40
Study 16448251 — intervention group
Group type: COMPARATOR
Intervention: Teeth washed with distilled water (control group)
Number of subjects: 40
Study 12663359 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling at 60 rpm
Number of subjects: 9
Study 12663359 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling at 80 rpm
Number of subjects: 9
Study 12663359 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling at 100 rpm
Number of subjects: 9
Study 12663359 — intervention group
Group type: COMPARATOR
Intervention: Isolated run (no cycling)
Number of subjects: 9
Study 14564591 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 13
Study 14564591 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 13
Study 8675502 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular allograft dermal matrix with split-thickness autograft
Number of subjects: 67
Study 8675502 — intervention group
Group type: COMPARATOR
Intervention: Split-thickness autograft alone (Control)
Number of subjects: 67
Study 8675502 — intervention group
Group type: EXPERIMENTAL
Intervention: Thin split-thickness autografts plus allograft dermal matrix
Number of subjects: 67
Study 1705140 — intervention group
Group type: EXPERIMENTAL
Intervention: F2 regimen (17 Gy in two fractions of 8.5 Gy 1 week apart)
Number of subjects: 369
Study 1705140 — intervention group
Group type: COMPARATOR
Intervention: FM regimen (30 Gy in ten fractions or 27 Gy in six fractions)
Number of subjects: 369
Study 1705140 — intervention group
Group type: EXPERIMENTAL
Intervention: Both F2 and FM regimens
Number of subjects: 369
Study 6824149 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate 100 micrograms/kg/minute with fentanyl 1 microgram/kg/minute for 10 minutes, followed by a maintenance dose at a rate of one-tenth this amount
Number of subjects: 90
Study 6824149 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine intravenously prior to induction
Number of subjects: 90
Study 31498138 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintendo Wii (NW) plus Conventional Exercises (CE)
Number of subjects: 45
Study 31498138 — intervention group
Group type: COMPARATOR
Intervention: Nintendo Wii (NW) alone
Number of subjects: 45
Study 31498138 — intervention group
Group type: COMPARATOR
Intervention: Conventional Exercises (CE) alone
Number of subjects: 45
Study 28743190 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP plus usual care
Number of subjects: 200
Study 28743190 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 200
Study 25936324 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipoprotein apheresis (LA)
Number of subjects: 50
Study 25936324 — intervention group
Group type: COMPARATOR
Intervention: Control (Cohort II)
Number of subjects: 50
Study 24434529 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecopipam 50 mg daily (weeks 1-2) and then 100 mg daily (weeks 3-8)
Number of subjects: 18
Study 21946197 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose heparin
Number of subjects: 146
Study 21946197 — intervention group
Group type: COMPARATOR
Intervention: Heparin-free
Number of subjects: 146
Study 19135805 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater amplitude of diurnal cortisol secretion
Number of subjects: 18
Study 19135805 — intervention group
Group type: COMPARATOR
Intervention: Lower amplitude of diurnal cortisol secretion
Number of subjects: 18
Study 17471090 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative esophagus retraction during anterior cervical surgery
Number of subjects: 92
Study 17471090 — intervention group
Group type: COMPARATOR
Intervention: Control group of 32 lumbar surgery patients
Number of subjects: 92
Study 15286134 — intervention group
Group type: EXPERIMENTAL
Intervention: Various methods for analysis of multiple outcomes (rank sum, ordinary least squares, general least squares, generalized estimating equations)
Number of subjects: 1063
Study 15286134 — intervention group
Group type: EXPERIMENTAL
Intervention: Two caries indices (based on average and maximum values of the methods)
Number of subjects: 1063
Study 15286134 — intervention group
Group type: EXPERIMENTAL
Intervention: New hybrid method
Number of subjects: 1063
Study 11918249 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration stimulation
Number of subjects: 95
Study 11918249 — intervention group
Group type: COMPARATOR
Intervention: Erotic videotape
Number of subjects: 95
Study 11918249 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of vibration and erotic videotape
Number of subjects: 95
Study 9084953 — intervention group
Group type: EXPERIMENTAL
Intervention: Faces Pain Scale
Number of subjects: 50
Study 9084953 — intervention group
Group type: EXPERIMENTAL
Intervention: Poker Chip Tool
Number of subjects: 50
Study 9084953 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Analogue Toy
Number of subjects: 50
Study 9084953 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal Rating Scale
Number of subjects: 50
Study 9084953 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral checklist
Number of subjects: 50
Study 7959330 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG
Number of subjects: 149
Study 7959330 — intervention group
Group type: COMPARATOR
Intervention: Control (no hCG)
Number of subjects: 149
Study 3605735 — intervention group
Group type: EXPERIMENTAL
Intervention: MTC 0.03 mg/kg
Number of subjects: 12
Study 3605735 — intervention group
Group type: COMPARATOR
Intervention: Saline 0.015 ml/kg
Number of subjects: 12
Study 28255736 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D/HD robotic scope
Number of subjects: 98
Study 28255736 — intervention group
Group type: COMPARATOR
Intervention: 2D/HD laparoscope
Number of subjects: 98
Study 28340322 — intervention group
Group type: EXPERIMENTAL
Intervention: DTPa‐HBV‐IPV/Hib formulation A (DATAPa‐HBV‐IPV/Hib)
Number of subjects: 721
Study 28340322 — intervention group
Group type: EXPERIMENTAL
Intervention: DTPa‐HBV‐IPV/Hib formulation B (DBTBPa‐HBV‐IPV/Hib)
Number of subjects: 721
Study 28340322 — intervention group
Group type: COMPARATOR
Intervention: Licensed DTPa‐HBV‐IPV/Hib vaccine (Infanrix hexa, GSK)
Number of subjects: 721
Study 25645987 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg three times per week
Number of subjects: 129
Study 25645987 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg on-demand
Number of subjects: 129
Study 25645987 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 129
Study 24171516 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous stem-cell transplantation after one additional cycle of induction chemotherapy
Number of subjects: 370
Study 24171516 — intervention group
Group type: COMPARATOR
Intervention: Control group (three additional cycles of induction chemotherapy)
Number of subjects: 370
Study 24171516 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous stem-cell transplantation
Number of subjects: 370
Study 24171516 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk patients in the transplantation group
Number of subjects: 370
Study 24171516 — intervention group
Group type: COMPARATOR
Intervention: High-risk patients in the control group
Number of subjects: 370
Study 21223597 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group participants (n = 175)
Number of subjects: 341
Study 21223597 — intervention group
Group type: COMPARATOR
Intervention: Usual care group participants (n = 166)
Number of subjects: 341
Study 19766757 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-bolus intravenous administration of sodium bicarbonate (20 mEq) plus standard hydration with sodium chloride
Number of subjects: 144
Study 19766757 — intervention group
Group type: COMPARATOR
Intervention: Standard hydration alone
Number of subjects: 144
Study 17675917 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulbutiamine + Donepezil (S + D)
Number of subjects: 0
Study 17675917 — intervention group
Group type: COMPARATOR
Intervention: Donepezil + Placebo (D + P)
Number of subjects: 0
Study 14995938 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane anaesthesia supplemented with intravenous remifentanil
Number of subjects: 14
Study 14995938 — intervention group
Group type: COMPARATOR
Intervention: Desflurane anaesthesia supplemented with epidural bupivacaine
Number of subjects: 14
Study 11746538 — intervention group
Group type: EXPERIMENTAL
Intervention: Central vein (CV) access
Number of subjects: 46
Study 11746538 — intervention group
Group type: COMPARATOR
Intervention: Peripheral vein (PV) access
Number of subjects: 46
Study 9541692 — intervention group
Group type: EXPERIMENTAL
Intervention: CD44v6-positive patients (n=219, 64.8% of the population)
Number of subjects: 338
Study 9541692 — intervention group
Group type: COMPARATOR
Intervention: CD44v6-negative patients (n=119, 35.2% of the population)
Number of subjects: 338
Study 8740308 — intervention group
Group type: EXPERIMENTAL
Intervention: Body contact with the mother during the first 90 minutes after birth
Number of subjects: 29
Study 8740308 — intervention group
Group type: COMPARATOR
Intervention: Kept in a cot during the first 90 minutes after birth
Number of subjects: 29
Study 2109643 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen lysine 500 mg (oral administration)
Number of subjects: 8
Study 2109643 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen 200 mg (intravenous injection)
Number of subjects: 8
Study 2109643 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen 400 mg (intravenous injection)
Number of subjects: 8
Study 7350046 — intervention group
Group type: EXPERIMENTAL
Intervention: Pruritus
Number of subjects: 236
Study 7350046 — intervention group
Group type: EXPERIMENTAL
Intervention: Jaundice
Number of subjects: 236
Study 7350046 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatomegaly
Number of subjects: 236
Study 7350046 — intervention group
Group type: EXPERIMENTAL
Intervention: Pigmentation
Number of subjects: 236
Study 7350046 — intervention group
Group type: EXPERIMENTAL
Intervention: Xanthomas
Number of subjects: 236
Study 7350046 — intervention group
Group type: EXPERIMENTAL
Intervention: GI bleeding
Number of subjects: 236
Study 7350046 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascites
Number of subjects: 236
Study 7350046 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertebral collapse
Number of subjects: 236
Study 7350046 — intervention group
Group type: EXPERIMENTAL
Intervention: Cirrhosis
Number of subjects: 236
Study 7350046 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitochondrial antibody titer
Number of subjects: 236
Study 31839281 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole (1 mg per day, oral)
Number of subjects: 3864
Study 31839281 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3864
Study 30810619 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab every month
Number of subjects: 45
Study 30810619 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab every 2 weeks
Number of subjects: 45
Study 30810619 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab every month
Number of subjects: 45
Study 30810619 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 45
Study 28188586 — intervention group
Group type: EXPERIMENTAL
Intervention: Habit formation intervention (workshop at baseline and follow-up booster phone call at week 4)
Number of subjects: 94
Study 28188586 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 94
Study 25822707 — intervention group
Group type: COMPARATOR
Intervention: Ureteroscopic lithotripsy (URSL)
Number of subjects: 232
Study 25822707 — intervention group
Group type: EXPERIMENTAL
Intervention: Retroperitoneal laparoscopic ureterolithotomy (RPLU)
Number of subjects: 232
Study 26863558 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertrophy Training (HT) with Evaluative Conditioning (EC)
Number of subjects: 231
Study 26863558 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertrophy Training (HT)
Number of subjects: 231
Study 26863558 — intervention group
Group type: EXPERIMENTAL
Intervention: Power Training (PT)
Number of subjects: 231
Study 26863558 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertrophy Training (HT) and Power Training (PT)
Number of subjects: 231
Study 23313202 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible nephroscopy during percutaneous nephrolithotomy
Number of subjects: 80
Study 23313202 — intervention group
Group type: COMPARATOR
Intervention: Standard percutaneous nephrolithotomy using rigid nephroscopy
Number of subjects: 80
Study 21550429 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol treatment (0.05mg/day)
Number of subjects: 32
Study 21550429 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 32
Study 18461844 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief supportive psychotherapy (BSP) training
Number of subjects: 18
Study 18461844 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy (CBT) orientation
Number of subjects: 18
Study 18461844 — intervention group
Group type: EXPERIMENTAL
Intervention: BSP training
Number of subjects: 18
Study 18461844 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior supportive therapy training
Number of subjects: 18
Study 16188948 — intervention group
Group type: EXPERIMENTAL
Intervention: SSc patients with thymus alterations
Number of subjects: 34
Study 16188948 — intervention group
Group type: EXPERIMENTAL
Intervention: SSc patients with disease duration ≤ 5 years
Number of subjects: 34
Study 16188948 — intervention group
Group type: EXPERIMENTAL
Intervention: SSc patients with serum anti-Scl70 antibodies
Number of subjects: 34
Study 16188948 — intervention group
Group type: EXPERIMENTAL
Intervention: SSc patients with thymus alterations post-thymectomy
Number of subjects: 34
Study 16188948 — intervention group
Group type: COMPARATOR
Intervention: Controls (age- and sex-matched)
Number of subjects: 34
Study 12686335 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 10 mg/day
Number of subjects: 0
Study 12686335 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg/day plus fenofibrate 200 mg/day
Number of subjects: 0
Study 12686335 — intervention group
Group type: COMPARATOR
Intervention: Fenofibrate 200 mg/day
Number of subjects: 0
Study 11052841 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadroparin (2 ml of 2500 anti-Xa-units/ml with a microporous catheter)
Number of subjects: 250
Study 11052841 — intervention group
Group type: COMPARATOR
Intervention: Control (no local drug delivery)
Number of subjects: 250
Study 11052841 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadroparin
Number of subjects: 250
Study 11052841 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 250
Study 9867333 — intervention group
Group type: EXPERIMENTAL
Intervention: LO2A (tear substitute containing glycerine and sodium hyaluronate)
Number of subjects: 25
Study 9867333 — intervention group
Group type: COMPARATOR
Intervention: Control (current tear substitute)
Number of subjects: 25
Study 7606629 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (three times daily for 6 days)
Number of subjects: 36
Study 7606629 — intervention group
Group type: COMPARATOR
Intervention: Placebo (three times daily for 6 days)
Number of subjects: 36
Study 3396674 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (200 micrograms or 150 micrograms)
Number of subjects: 18